PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
10-Oct-2023 Novotech Secures Consecutive Frost & Sullivan CRO Company of the Year Award Novotech
10-Oct-2023 Elsevier launches new PharmaPendium, empowering pharma companies to bring novel drugs to market faster and increase success of regulatory submissions Elsevier
10-Oct-2023 LYNPARZA (OLAPARIB) ACCEPTED FOR USE IN SCOTLAND AS ADJUVANT TREATMENT FOR PATIENTS WITH GERMLINE BRCA-MUTATED HER2-NEGATIVE HIGH RISK EARLY BREAST CANCER AstraZeneca
10-Oct-2023 Creative Diagnostics Launches New Azaperone Test Reagents for Research Applications Creative Diagnostics
10-Oct-2023 Creative Diagnostics Launches Checkerboard Assay Services Creative Diagnostics
10-Oct-2023 Creative Diagnostics Launches New Anti-Small Molecule Label Antibodies to Facilitate NALFIA Development Creative Diagnostics
06-Oct-2023 Moberg Pharma has completed enrollment to the Phase 3 study for MOB-015 in North America Moberg Pharma
05-Oct-2023 Agomab Receives FDA Fast Track Designation for AGMB-129 in Fibrostenosing Crohn’s Disease and Starts STENOVA Phase 2a Clinical Trial Agomab
05-Oct-2023 Veranova Announces Appointment of New Advisory Board Veranova
05-Oct-2023 Forxiga met primary endpoint in T2NOW Phase III trial, one of the largest paediatric type 2 diabetes studies performed to date AstraZeneca
04-Oct-2023 Phastar Net-Zero Target Approved by the Science Based Targets Initiative Phastar
04-Oct-2023 CTMC partners with ScaleReady to automate, close, and scale for greater patient accessibility ScaleReady
04-Oct-2023 PureTech Founded Entity Vedanta Biosciences Announces First Patient Dosed in Phase 2 Clinical Trial of VE202 for the Treatment of Ulcerative Colitis and Receives Fast Track Designation PureTech Health plc
04-Oct-2023 Myricx Expands its ADC Expertise with the Appointment of Francesca Zammarchi as CSO Myricx
04-Oct-2023 Rejuvenate Biomed announces positive results from Phase 1b clinical trial with RJx-01 in sarcopenia Rejuvenate Biomed NV
04-Oct-2023 CellProthera completes enrollment in Phase I/IIB trial for post-myocardial infarction cell therapy CellProthera
04-Oct-2023 Velocity opens three UK greenfield clinical research sites Velocity
04-Oct-2023 Janssen Enters into Agreement with Sanofi to Advance Potential First-In-Class Vaccine Program Janssen
03-Oct-2023 Cassava Sciences Completes Patient Enrollment for Pivotal Phase 3 Clinical Trial of Oral Simufilam in Alzheimer’s Disease Cassava Sciences
03-Oct-2023 Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System Amber Implants